Read the announcement! Focusing on the heart provides a potential entry space, which at this point is clinically unmet. Why ask others, on here, when you should just read and ascertain the information from the source? Management being smart imo.
- Forums
- ASX - By Stock
- NYR
- Ann: NYR Advances Xolatryp Phase IIa Trial in Cardioprotection
NYR
nyrada inc.
Add to My Watchlist
0.00%
!
30.0¢

Ann: NYR Advances Xolatryp Phase IIa Trial in Cardioprotection, page-39
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.43M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 29.0¢ | $245.6K | 829.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29101 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 311729 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29101 | 0.295 |
5 | 160000 | 0.290 |
7 | 171000 | 0.285 |
6 | 128000 | 0.280 |
2 | 10579 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 311729 | 2 |
0.310 | 29700 | 1 |
0.320 | 5000 | 1 |
0.325 | 75000 | 1 |
0.330 | 7200 | 1 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |